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Abstract
Background: Ovarian tissue cryopreservation is an emerging technique, also addressed to very young cancer
patients, for whom it is not possible to perform an ovarian stimulation for oocytes freezing, before gonadotoxic
treatment. In this cases, ovarian tissue must be cryopreserved for a long period of time and it is very important to
know if it maintains fertility function after a long period of storage. Here we aimed to assess the effect of long-term
storage on preservation and viability of cryopreserved human ovarian tissue.
Methods: Descriptive study of three cases of cancer patients whose cryopreserved ovarian tissue remained stored
for 18 years. Long-term stored tissue was examined by histological and immunohistochemical analysis, transmission
electron microscopy, TUNEL assay and LIVE/DEAD viability/citotoxicity test.
Results: Ovarian tissue stored for 18 years showed a good morphology. Follicles presented negative staining for
estrogen and progesterone receptors, positive staining for ki67 in granulosa cells and/or oocytes and for bcl2 in
granulosa cells. Regarding stroma, patch/focal positive expression was found for estrogen receptor and ki67,
diffusely positive expression for progesterone receptor and bcl2. After long-term storage, ultrastructural examination
showed sub-cellular integrity of follicles and interstitial oedema foci. No apoptosis was observable by TUNEL assay.
Stromal cell viability remained >97 % during the culture period.
Conclusion: The evaluation of different aspects of the tissue provides evidence that the storage time does not impact
on tissue quality and gives hope especially to cancer girls, whose tissues could remain cryopreserved for a very long time.
Keywords: Human ovarian tissue cryopreservation, Long-term storage, Tissue quality
Abbreviations: ER, Estrogen receptor; PR, Progesterone receptor; TUNEL, Terminal deoxynucleotidyl transferase
dUTP nick end labeling; α-MEM, Alpha minimum essential medium; ITS, Insulin, transferrin, selenite; HS, Human
serum; NAC, N-acetyl-cystein; D-PBS, Dulbecco’s phosphate-buffered saline; LH, Luteinizing hormone
Background
Recent advances in the diagnosis of cancer and the
availability of new protocols of chemo- and radio-
therapy have significantly increased the life span of
children, adolescents and adults with cancer [1]. Un-
fortunately, these treatments are gonadotoxic and can
severely affect or totally destroy the reproductive po-
tential of patients [2].
Ovarian tissue cryopreservation represents a promising
strategy to preserve reproductive function and steroido-
genic activity in patients with a high risk of premature
ovarian failure. This technique can be performed at any
time in the ovarian cycle, thereby avoiding delays in
starting therapy; it is particularly indicated in patients
with hormone sensitive tumors and it is the only avail-
able option to preserve ovarian function in prepubertal
girls [3, 4].
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At remission of disease, the cryopreserved ovarian tis-
sue can be reimplanted in the patients to restore the
ovarian function. Many patients remained interested in
maintaining cryostorage of their ovarian tissue beyond
an initial 5-year period [5] as ovarian tissue cryopreser-
vation avoids the sequelae of preterm menopause and al-
lows to postpone child bearing until early 40 years. The
storage time of the ovarian tissue becomes even longer
in youngest patients, for example prepubertal patients,
at the time of the cryopreservation.
To date, studies on ovarian tissue storage are limited
in numbers [6] and little is known about the influence of
several years of storage on integrity and viability of the
cryopreserved ovarian tissue.
The aim of this study was to evaluate the effect of 18 years
of storage on preservation and viability of ovarian tissue
cryopreserved by slow-freezing/rapid-thawing protocol.
Methods
Patients
The study was performed on the ovarian tissue of three
patients: patient 1, 32 years suffering from right ovarian
adenocarcinoma (in this patient an ovarian biopsy was
retrieved from the healthy left ovary); patient 2, 36 years
suffering from breast cancer; patient 3, 31 years suffering
from colon cancer. The patients cryopreserved the ovar-
ian tissue at Gynecology and Physiopathology of Human
Reproductive Unit of S. Orsola-Malpighi Hospital of
Bologna (Italy) in 1997.
Study design
The ovarian tissue of the three patients was harvested by
laparoscopy and treated as reported in Fabbri et al. [7]: a)
one or two cortical strips per patient were immediately
fixed in formalin for histological and immunohistochemi-
cal analysis (control fresh tissue) and the remaining cor-
tical strips were cryopreserved by slow-freezing protocol;
b) after short-term storage (120 days), one or two cortical
strips per patient were thawed and fixed for histological
and immunohistochemical analysis, to verify the efficiency
of the ovarian tissue cryopreservation procedure.
In the present study, one or two cortical strips of the
same three patients were thawed after long-term storage
(18 years) and evaluated for:
a) Ovarian tissue quality by histological and
ultrastructural analysis to assess the morphological
features of follicles and stromal cells, similarly to
what performed in Fabbri et al. [7];
b) Maintenance of ovarian potential ability to respond to
reproductive hormones by estrogen and progesteron
receptor antibodies in immunohistochemistry, since
the steroids are well-recognized regulators of
folliculogenesis;
c) Preservation of cell proliferation and anti-apoptotic
activity as determined by anti-ki67 and anti-Bcl2
antibodies in immunohistochemistry;
d) Incidence of apoptosis phenomena by TUNEL assay
that highlights DNA fragmentation results from
apoptotic signaling cascades;
e) In-vitro cell viability by LIVE/DEAD viability/
citotoxicity test that discriminates live from dead cells
by simultaneously staining with green-fluorescent
calcein-AM, to indicate intracellular esterase activity,
and with red-fluorescent ethidium homodimer-1, to
indicate loss of plasma membrane integrity.
Slow-freezing/rapid-thawing protocol
Ovarian tissue was cryopreserved using a slow-freezing
protocol described by Fabbri et al. [7]. In brief, ovarian
cortical strips were placed in plastic cryovials (Intermed
Nunc Cryotubes, Roskilde, Denmark) containing 1.8 ml
of “freezing solution” consisting of 1.5 M 1,2-propane-
diol (PROH - Fluka Chemica, Sigma Aldrich SrL; Milan,
Italy), 0.2 M sucrose (Fluka Chemica, Sigma Aldrich SrL;
Milan, Italy), and 30 % heat-inactivated human serum
(HS - provided by the Transfusion Centre of S. Orsola-
Malpighi Hospital) in Dulbecco’s phosphate-buffered sa-
line (DPBS-Gibco, Life Technologies, Paisley, Scotland)
and maintained at 0 °C in an ice bath. The cryovials
were transferred to a rolling system (Continents instru-
ment, Amityville, USA) for 30 min at 4 °C to allow the
cryoprotectant to enter the tissue; they were then cooled
in a programmable freezer (Planer Kryo 10/1,7 Series III,
SAPIO Life, Milan, Italy) allowing the gradual reduction
of the temperature from 0 to −140 °C. The starting
temperature was 0 °C; then it was slowly reduced to −9 °C
at a rate of 2 °C/min. Ice nucleation was induced manually
at −9 °C (seeding). After a holding time of 10 min
at −9 °C, the cryovials were cooled slowly to −40 °C at a
rate of 0.3 °C/min and then rapidly to −140 °C at a rate of
10 °C/min. After 10 min of temperature stabilization, the
cryovials were transferred into liquid nitrogen tanks and
stored until thawing.
Frozen ovarian tissue was thawed using a modified
rapid-thawing protocol described by Fabbri et al. [8]. In
brief, the cryovials were air-warmed for 30 s and then
immersed into 37 °C water bath for 2 min. The cryopro-
tectants were removed at 4 °C by four-stepwise dilution:
(i) 0.76 M PROH, 0.175 M sucrose, 30 % HS in DPBS
for 5 min; (ii) 0.26 M PROH, 0.175 M sucrose, 30 % HS
in DPBS for an additional 5 min; (iii) 0.175 M sucrose,
30 % HS in DPBS for 10 min and finally, (iv) DPBS sup-
plemented with 30 % HS for 20 min.
Histological - immunohistochemical - TUNEL analysis
Frozen/thawed cortical strips were embedded in paraffin
blocks and nine 4 μm thickness serial sections were
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obtained per block: the first, third and seventh were
stained with hematoxylin and eosin (Merck, Darmstadt,
Germany), to assess the morphological features of folli-
cles and stromal cells. Follicle development stage was es-
tablish according to Gougeon classification [9].
The second, fourth and sixth sections were used for
immunohistochemistry, as described in Fabbri et al. [7],
and incubated overnight at 4 °C with the following pri-
mary antibodies: anti-estrogen receptor (ER) clone 1D5
(1:20, Bio Genex, San Ramon, CA), anti-progesterone re-
ceptor (PR) clone 1A6 (1:20, Bio Genex, San Ramon,
CA), anti-proliferating antigen Ki67 (1:80, Bio Genex,
San Ramon, CA), anti-protein Bcl2 (1:80, Dako, Carpin-
teria, CA). An En Vision monoclonal immunoenzymatic
system was used for immunnohistochemical detection
(Dako). The reaction was developed in 3,3-diaminoben-
zidine (DAB, Sigma, St. Louis, MO, USA). Finally, the
sections were counterstained with Mayer’s hematoxylin
for 10 s, dehydrated, and mounted in Eukitt. Control
procedures were undertaken simultaneously to ensure
the specificity of immunostaining [7]. Sections without
primary antibodies were used as a negative control and
sections of human breast cancer were used as a positive
control. Follicle and stromal positivity for the primary
antibodies were evaluated at 200X magnification under a
Leitz microscope. Follicles with oocyte nucleus and at
least one stained granulosa cell were considered positive.
The fifth, eighth and ninth sections were collected
(Superfrost-plus slides Menzel-Gläser, Braunschweig,
Germany) for terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) analysis using the cell
death detection kit conjungated with horseradish perox-
idase (Roche, Mannheim, Germany), according to the
manufacturer’s instructions. Briefly, after deparaffination,
rehydratation and washing with phosphate-buffered sa-
line, four to six sections were immersed in 10 mM
citrate buffer and underwent antigen retrieval in a
microwave for 5 min (350 W). Then the slides were in-
cubated with 50 mL of TUNEL reaction mixture and in-
cubated at 37 °C for 60 min in the dark inside a
humidified chamber.
As positive control, sections were incubated with DNase
I (3000U/ml in 50 mM Tris–HCl, pH 7.5, 1 mg/ml BSA)
for 10 min at 15–25 °C to induce DNA strand breaks,
prior to labeling procedure; as negative control, sections
were incubated with label solution only (without terminal
transferase) instead of TUNEL reaction mixture.
The apoptotic signal was recorded as positive when
dUTP stained the nucleus brown. Follicles were consid-
ered damaged when the oocyte nucleus and/or more
than two of granulosa cells were stained in brown by
dUTP. The number of apoptotic stromal cells was ana-
lyzed in a 100 mm2 (randomly assigned in the sections)
and was counted three times and then averaged. The
percentage of apoptotic cells was calculated as follows:
apoptotic cell number/total cell number × 100 and quan-
tified in a double blind fashion using a Leitz Diaplan
light microscope equipped with a CCD JVC video cam-
era. Digitized images were analyzed with Image ProPlus
software.
All sections were examined on a blind fashion by two
different pathologists.
Ultrastructural analysis
Frozen/thawed (after long-term storage) cortical strips
were fixed in a 4 % buffered paraformaldehyde solution
at pH 7.4 overnight at 4 °C. After osmium tetroxide
postfixation and alcohol dehydration, the samples were
embedded in epoxy resin (Araldite, Fluka, Switzerland)
and then cut using an ultramicrotome (Ultracut, Reichert,
Vienna, Austria). Sixty-nm thick sections were collected
on 200 mesh grids, stained with uranyl acetate followed by
lead citrate and viewed using a Philips 410 T transmission
electron microscope at 80 kV, in order to evaluate the in-
tegrity of oocytes, granulosa and stromal cells according
to previously reported subcellular criteria [8].
Viability/Cytotoxicity LIVE/DEAD assay
Frozen/thawed (after long-term storage) cortical strips were
digested in an enzymatic solution containing Epicult-B
Basal Medium (StemCell Technologies) and Collagenase/
Hyaluronidase (3000 U/mL Collagenase, 1000 U/mL Hyal-
uronidase. Stemcell Technologies Milan, Italy) at 37 °C for
4 h. The digested cell solution was centrifuged at 200 g for
3 min and the pellet was re-suspended in 1 ml culture
medium composed of α-MEM (Alpha Minimum Essential
Medium, Sigma, Italy), 1 % ITS (5 μg/mL insulin, 5 μg/mL
transferrin, 5 ng/mL selenite, Sigma, Italy), 20 % HS,
25 mmol/l NAC (N-Acetyl-cystein, Sigma, Italy), and
antibiotics. Cells were then cultured in 2 ml of
medium in sterile 35 mm petri dishes at 37 °C and
6 % CO2 for 15 days. Culture medium was replaced
with pre-equilibrated fresh medium every 48 h.
20.000 cells were seeded on a sterile glass coverslip
inside 35 mm petri dishes and cell viability was
checked after 2 and 7 days of culture. At the end of
culture period the cells were washed with Dulbecco’s
phosphate-buffered saline (D-PBS) and treated with
Viability/Cytotoxicity LIVE/DEAD Kit (Molecular Probes,
Invitrogen, Milan, Italy) based on the simultaneous
determination of live and dead cells with two probes,
calcein-AM and ethidium homodimer-1(EthD-1). 0.5 mM
Calcein-AM and 4 mM EthD-1 were added to culture
dishes for 30 min at room temperature. Following in-
cubation, the coverlisp was cleaned with D-PBS,
mounted on the microscope slide and immediately
viewed under the fluorescent microscope (Leica CTR6000,
Leica Microsystems, Germany).
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Results
Histological - immunohistochemical - TUNEL analysis
After long-term storage, frozen/thawed ovarian tissue
appeared well-preserved. Most of follicles were prim-
ordial (Fig. 1a); follicles at advanced stage of development
(primary, secondary, pre-antral) were also present (Fig. 1b).
Stromal cells showed an intact architecture: oval- to
spindle-shaped nucleus with dispersed chromatin; no
interstitial oedema or vacuoles were present (Fig. 1a,b).
Results of immunohistochemical analysis showed a
similar staining pattern distribution in the three patients.
In particular, estrogen receptors (ER) were negative in
all examined follicles and showed a patch/focal expres-
sion (<10 % positive cells) in stromal cells (Fig. 2a,b).
Akin progesterone receptors (PR) were negative in folli-
cles but diffusely positive (>50 % positive cells) in stro-
mal cells (Fig. 2c,d). Concerning ki67 protein, a positive
nuclear staining was found in both the granulosa cells
and/or oocytes in 44 % (21/48) of the frozen/thawed fol-
licles, while no positive staining was observed in stromal
tissue (Fig. 2e,f ). As to bcl2 protein (bcl2), positive
staining was found in the granulosa cells of secondary/
preantral follicles, but not in the oocytes. Stromal tissue
was diffusely bcl2 stained (Fig. 2g,h).
Analogous results were observed in fresh and frozen/
thawed (after short term storage) tissue of the same
three patients and reported in Fabbri et al. [7].
No TUNEL-positive cells were found in follicles at
primordial stage (Fig. 3a) and at more advanced stage of
development (Fig. 3b) as well as in the stroma (Fig. 3a,b)
of frozen/thawed tissue after long-term storage.
Ultrastructural analysis
TEM examination of frozen/thawed follicles after long-
term storage, showed large oocytes with regular nuclei
and finely dispersed chromatin (Fig. 4a), intact nuclear
membranes and nuclear pores (Fig. 4b). Mitochondria,
free ribosomes, rough and smooth endoplasmic reticulum,
Golgi apparatus and occasional lipid inclusion and lipofus-
cin bodies were observed in the oocyte cytoplasm. In
particular, mitochondria appeared typically round, with a
low-density matrix, clustered around a dense and amorph-
ous intermitochondrial substance (Fig. 4b); the Golgi
apparatus was well developed, consisting of numerous
flattened cisternae and vesicles (Fig. 4c); stacks of annulate
lamellae were recorded in the nucleus proximity (Fig. 4d).
Granulosa cells with flat nuclei with dispersed euchroma-
tin were adherent to the oocyte (Fig. 4e).
Stroma cells showing large euchromatic oval nuclei
and nuclear clefts (Fig. 4f ) were embedded in a collage-
nous matrix. Empty clear stromal areas were seen and
considered a consequence of cryodamage.
Viability/Cytotoxicity LIVE/DEAD Kit assay
The Viability/Cytotoxicity LIVE/DEAD assay performed
on stromal cells enzymatically isolated from frozen/
thawed tissue after long-term storage showed viable cells
after 2 (Fig. 5a) and 7 (Fig. 5b) days of culture; these
cells had the ability to grow without the growth factor
supplementation. During the culture period the viability
of cells remained always >97 %.
Discussion
The ovarian tissue cryopreservation is a complex tech-
nique that requires experience and validation [8, 10, 11].
Although reproductive performance and recovery of
regular cyclic function after transplantation of cryopre-
served ovarian tissue are encouraging [12–14], several
studies report a decreased reproductive potential of
frozen ovarian tissue transplantation than fresh one
[15–18]. It might be likely related to the cryopreser-
vation procedure that determine oocyte/stroma dam-
age [19, 20] or to ischemic injury to follicles, caused
by the freeze-thaw procedures in cryopreserved ovar-
ian grafts [21–23].
A recent study investigated the influence of the storage
time (30 and 180 days) on the magnitude of tissue dam-
age [6]. The authors found that the short-term storage
of ovarian tissue did not appear to compromise follicle
integrity and steroidogenic capacity of the tissue.
Fig 1 Morphological appearance of human cryopreserved ovarian tissue after long-term storage. a Primordial follicles, b secondary follicle
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Fig. 2 Immunohistochemical staining for ER (a, b), PR (c, d), ki-67 (e, f) and bcl2 (g, h) in follicles and stroma of human cryopreserved ovarian
tissue after long-term storage. ( ) Negative staining; ( ) Positive staining
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Fig. 3 TUNEL staining of follicles and stroma of human cryopreserved ovarian tissue after long-term storage. a Primordial follicle; b Secondary
follicle. No apoptosis incidence in primordial (a) and secondary follicles (b) as well as in the stroma (a, b)
Fig. 4 Transmission electron microscopy of human cryopreserved ovarian tissue after long-term storage. A primordial/primary follicle: the oocyte shows
a nucleus (n) having finely dispersed chromatin and cytoplasm (oc) rich in organelles; a layer of flattened/cuboidal granulosa cells (gc) surrounding oocyte
cytoplasm; B perinuclear aggregates of rounded mitochondria (m) having moderate electron dense matrices, ( ) nuclear pores; C Golgi apparatus; D
annulate lamellae consist of membrane-bound cisternae traversed by pore complexes; E granulosa cells with oval shaped nuclei (n); f stromal cells
with oval shaped nuclei (n) and slight band of peripherically condensed chromatin (pch). Empty interstitial areas are detectable ( )
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However, it must be considered that usually the ovar-
ian tissue remains frozen for a very longer time period.
In fact, the request to re-implant the cryopreserved
ovarian tissue usually occurs after at least five years from
the end of therapies, when oncologists declare the pa-
tient completely healed [5]. This period may dragging on
further in the case of diseases that require prolonged
treatments, or in the case of pediatric patients.
As to date there are no reports describing the impact
of long-term storage on cryopreserved ovarian tissue,
the present study aimed to investigate the morpho-
functional features of frozen ovarian tissue stored for
18 years.
The efficiency of cryopreservation procedure was pre-
viously determined by the comparison of fresh and fro-
zen/thawed tissue after short-term storage as reported in
Fabbri et al. [7]. The success of freezing/thawing proto-
col was evidenced by a good stromal and follicular
morphology in the specimens, maintenance of ovarian
antigenicity (ER and PR expression), of cellular prolifera-
tion (ki67 expression), and of anti-apoptotic index (Bcl-2
expression). During the last 12 years our research group
worked in order to optimize the cryopreservation protocol
to improve the preservation of ovarian tissue by checking
the seeding temperature, which is a crucial step of slow-
freezing/rapid-thawing protocol, and by testing different
concentrations of cryoprotectants and protein support.
The best preservation of morphological characteristics
was obtained using the freezing-thawing protocol in which
the seeding was performed at −9 °C [24, 25] and the con-
centrations of cryoprotectants were 1.26 M PROH and
0.175 M sucrose added with 30 % human serum [8]. This
cryopreservation protocol was further modified perform-
ing all thawing steps at 4 °C rather than at room
temperature. The ultrastructural analysis showed a reduc-
tion of interstitial oedema and vacuolation in the stroma
when the cryoprotectants were removed at lowest
temperature (data not published). This modified freezing-
thawing protocol is now in use at our Centre.
In the present study we evaluated the effect of long-
term storage on tissue preservation by using the same
analysis performed in Fabbri et al. [7]. Histological ana-
lysis showed a well-preserved morphology of the single
tissue components: oocytes, granulosa and stromal cells.
In all follicles there was no specific positive staining for
estrogen and progesterone receptors. According to our
previous study [7], this result could be related to the fol-
licle size composition seen in our samples: in fact the
samples analyzed contained primordial, intermediary,
primary and secondary, that do not express ER and PR
[26]. ER expression is evidenced in antral and pre-
ovulatory follicles, before and during the luteinizing
hormone (LH) surge; PR expression is evidenced in
pre-ovulatory follicles during the LH surge and in lu-
teinized granulosa cells after ovulation. On the con-
trary, a positive staining for ER (focal) and for PR
(diffuse) was observed in the stroma. Expression of
steroid receptors in the stroma tissue around small
follicles has also been consistently observed in other
species [27–30]. Steroids might indirectly regulate the
small follicles by modulating the stromal cell-follicular
interactions as well as through direct regulation of
follicular cells. One potential mechanism by which
steroids may indirectly regulate early follicular growth
through interaction with the stromal cells is through regu-
lation of small growing follicle vascularization [31, 32].
We also assessed the proliferative status of the ovarian
cell population by monoclonal ki67 immunostaining.
The monoclonal ki67 antibody recognizes a nuclear anti-
gen which is expressed in all stage of the cell cycle ex-
cept G0, so it represents a good index of the capacity of
cryopreserved tissue to proliferate after thawing. A posi-
tive staining was found in the most of follicles, including
oocytes and granulosa cells, suggesting that follicles
could resume the mitotic cycle and subsequently grow.
No positive staining was found in stromal cells.
Fig. 5 LIVE/DEAD fluorescence staining of stromal cells isolated from
human cryopreserved ovarian tissue after long-term storage and
cultured for 2 days (a) and 7 days (b). Green cells are alive cells, red
cells are dead cells
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The high percentage of positivity for anti-apoptotic
bcl2 protein in granulosa cells as well as in stromal cells
also indicates the good preservation of tissue after
18 years of storage.
The comparison of current results with those of fresh
and short-term stored tissue appeared very encouraging
and suggested that storage time does not influence tissue
preservation, antigenicity and proliferative potential.
In order to provide more detailed examination of ovar-
ian tissue cryopreserved and stored for a long period, we
also performed additional analysis, such as TUNEL
assay, ultrastructural examination by transmission elec-
tron microscopy and in vitro-culture with LIVE/DEAD
assay.
TUNEL assay is a standard technique for the detection
of apoptosis in tissue sections. It is very sensitive and
widely used, although it is prone to technical problems,
mostly related to DNA strand-breaks associated with ex-
cessive levels of proteinase digestion, with fixation and
processing procedures, or with the action of section cut-
ting or other various pretreatments [33].
In the present study TUNEL assay, together with the
immunostaining for the bcl2 anti-apoptosis-associated
protein, allowed to have a countercheck of absence of
apoptosis phenomena in the stored tissue.
Ultrastructural analysis allowed to assess the real in-
tegrity of sub-cellular components and to detect features
of cryodamage not observable using light microscopy
[34, 35]. In fact, transmission electron microscopy evi-
denced foci of interstitial oedema, likely due to tissue
rehydratation occurring during the thawing procedure.
This kind of cryodamage is often observed in the ovarian
tissue cryopreserved by slow freezing/rapid thawing
protocol [8, 35].
Since the morphological and antigenic integrity of the
tissue immediately after thawing may not reflect its true
state [34, 35], the viability of cryopreseved human ovar-
ian tissue was demonstrated by follicle development, in-
tense proliferation (by immunoexpression of cytokeratin
and ki67) and neoangiogenesis (by immunoexpression of
von Willebrand factor) in the frozen-thawed cultured
tissue [24, 25, 36].
We evaluated the viability of frozen/thawed tissue
using stromal cell culture by the LIVE/DEAD test. We
demonstrated that stromal cells were viable and capable
of growing in culture after the cryopreservation proce-
dures and long-term storage.
Therefore, the evaluation of different aspects of the tis-
sue gives a complete picture of the frozen/thawed tissue
providing evidence that the time of storage does not im-
pact on the morphological, antigenic preservation of the
tissue including its proliferation potential and vitality.
In order to obtain a good tissue quality after cryo-
preservation it is very important that tissue is treated
with extreme accuracy by experienced and highly quali-
fied staff. Moreover any temperature change during tis-
sue storage has to be prevented.
Of course only the recovery of ovarian function after
replanting could give proof of the true capabilities of the
cryopreserved and stored ovarian tissue. A recent report
describes the efficiency of slow-freezing/rapid-thawing
procedure to restore fertility after transplantation of
ovarian tissue cryopreserved during childhood and stor-
age for 10 years [13]. This paper shows for the first time
the possibility of restoring endocrine function and
obtaining the birth of a healthy baby from ovarian tissue
harvested before puberty.
Unfortunately we could not have this confirmation
since the patients have donated their tissue for research
purpose. However, the follicular development in graft
sites and the recovery of ovarian function for more than
2 years after transplantation of ovarian tissue cryopre-
served using the slow-freezing/rapid-thawing protocol,
described in Fabbri et al. [37], provides evidence of the
feasibility of the procedure.
We also compared the slow-freezing/rapid-thawing
protocol with the vitrification/warming protocol [38]. In
agreement with Isachenko et al. [39], Rahimi et al. [40]
and Oktem et al. [41], the slow-freezing/rapid-thawing
gave better results than vitrification/warming. The ultra-
structural analysis of vitrified follicles evidenced irregu-
larly shaped oocyte nuclei with slightly thickened
chromatin, broken or swollen mitochondria, vacuoles
and clarification of cytoplasm. The laser scanning con-
focal microscopy analysis of bioenergetic/oxidative status
indicated a severe functional damage in vitrified tissue,
with reduced mitochondrial oxidative phosphorylation
activity associated with a decrease in the mitochondrial
capacity to synthesize reactive oxygen species.
Therefore, the conventional slow-freezing/rapid-thawing
remains at this moment the goal standard technique
for ovarian tissue preservation. Further studies will be
absolutely necessary and essential to optimize the vit-
rification protocol in order to switch from the con-
ventional freezing to vitrification for human ovarian
tissue cryopreservation.
Conclusions
The data of the present study support the validity
of our cryopreservation and storage procedures and
are very reassuring for ovarian tissue cryopreserva-
tion in prepubertal girls who will keep their ovarian
tissue stored for long time. This finding is noteworthy
for the safety of long-term banking in oncofertility
programs.
Of course only the recovery of ovarian function after
replanting could provide proof of the true capabilities of
the cryopreserved and stored ovarian tissue.
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